Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Prepaid Assets: 2015-2025

Historic Prepaid Assets for Voyager Therapeutics (VYGR) over the last 10 years, with Sep 2025 value amounting to $6.6 million.

  • Voyager Therapeutics' Prepaid Assets fell 21.35% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 21.35%. This contributed to the annual value of $7.9 million for FY2024, which is 49.40% up from last year.
  • As of Q3 2025, Voyager Therapeutics' Prepaid Assets stood at $6.6 million, which was down 32.27% from $9.8 million recorded in Q2 2025.
  • Voyager Therapeutics' Prepaid Assets' 5-year high stood at $10.1 million during Q1 2021, with a 5-year trough of $3.4 million in Q2 2022.
  • In the last 3 years, Voyager Therapeutics' Prepaid Assets had a median value of $6.6 million in 2025 and averaged $6.8 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first soared by 91.52% in 2021, then crashed by 64.16% in 2022.
  • Voyager Therapeutics' Prepaid Assets (Quarterly) stood at $3.4 million in 2021, then spiked by 57.40% to $5.4 million in 2022, then declined by 1.41% to $5.3 million in 2023, then skyrocketed by 49.40% to $7.9 million in 2024, then dropped by 21.35% to $6.6 million in 2025.
  • Its Prepaid Assets was $6.6 million in Q3 2025, compared to $9.8 million in Q2 2025 and $7.1 million in Q1 2025.